Germany risks missing out on new drugs, AstraZeneca CEO tells paper

FRANKFURT, April 21 (Reuters) - AstraZeneca's CEO told daily Handelsblatt on Tuesday that Germany risks missing out on new ...
News.az

AstraZeneca warns Germany could miss out on new drugs

Speaking to German newspaper Handelsblatt, CEO Pascal Soriot said proposed cost-cutting measures in the country’s healthcare ...
Devdiscourse

Germany's Pharmaceutical Future: At Risk Due to Spending Caps?

AstraZeneca's CEO warns that Germany might miss out on new drug launches if it continues its plans to limit pharmaceutical spending. Proposed regulations might hinder drug introductions, affecting ...
AOL

Blood-clot reports cause AstraZeneca COVID vaccine to be suspended again in Germany for people under 60

Use of the AstraZeneca COVID-19 vaccine was suspended again Tuesday in Germany for people under 60 years old after a series of patients reported experiencing blood clots. Authorities say 31 people — ...
Bloomberg L.P.

AstraZeneca Gets Rare Sell as Deutsche Bank Has Pipeline Worries

AstraZeneca Plc got a rare sell rating on Thursday as Deutsche Bank AG analysts downgraded the British drugmaker, taking a more skeptical view on the company’s drug pipeline, in particular for breast ...